Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

NTUH purchased to install CytoCare Robot during 2009

Health Robotics announced that National Taiwan University Hospital (NTUH) has purchased and agreed to immediately install its flagship CytoCare Robot during 2009. Separately, it also announced that it has signed an exclusive 3-year distribution, licensing, and support contract with Pinnaclemed [a Double Success Co. Ltd. subsidiary]. Both NTUH and Pinnaclemed desire to safely, accurately, and cost-effectively automate the preparation of hazardous Oncology I.V. Admixtures with Health Robotics' CytoCare Robot in Taiwan.

"We are very excited to install CytoCare at one of the most prestigious Asian institutions such as NTUH, well known for its commitment for the First in Asia Program, a well respected quality standard. After Malaysia, Australia, and Japan, NTUH will represent CytoCare's fourth country installation in Asia/Pacific, a number that we expect to double over the next six months with successful ongoing activities in Singapore, Indonesia, Vietnam, China, India, and New Zealand," stated Werner Rainer, Health Robotics' CEO.

Health Robotics and National Taiwan University Hospital started Cytocare discussions over 2 years ago and embarked on a journey to satisfy NTUH's country-specific needs in reference to the automation of Hazardous IV Admixtures. After extensive due diligence and 2009 budget approval, NTUH's Oncology Pharmacy Director Ms. Joyce Chen and Health Robotics' General Counsel Mr. Gaspar DeViedma formalized an agreement last week, including the quick installation of CytoCare at NTUH in October-November 2009. Subsequently, Health Robotics selected Double Success as its exclusive CytoCare partner in Taiwan and executed an agreement for the next 3 years, including both companies' cooperation in the CytoCare installation and technical support for NTUH.

"We are delighted to have been chosen by Health Robotics as their exclusive CytoCare partner in our core market of Taiwan. CytoCare, the only existing Oncology IV Admixtures Robot in the world, represents an ideal complement to Double Success medical portfolio of products and services, including Intuitive Surgical's daVinci Surgery Robot. We are very impressed that a small foreign company like Health Robotics could accomplish what they did at NTUH on their own, including the budget approval, a feat unheard of in Taiwan for a foreign company. It is indeed a testament to CytoCare's features, benefits, and customer testimonials from all over the world that made the NTUH's contract possible. We look forward to take the "baton" from Health Robotics and continue their work in our country, expanding the reach of CytoCare to other hospitals in Taiwan," stated Eddy Liu, General Manager of Double Success Co., Ltd.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs], i.v.STATION [non-hazardous IVs], i.v.SOFT [workflow engine] and the future development of TPNstation, have and will greatly contribute to ease global hospitals' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and sterility risks, and to work more efficiently, increase throughput, reduce waste, and contain costs. For more information, please visit http://www.health-robotics.com

Source: Health Robotics